Recombinant Brucella suis biovar 1 UPF0283 membrane protein BR1033/BS1330_I1029, also referred to as BR1033 or BS1330_I1029, is a protein expressed in Brucella suis biovar 1 . It is sometimes produced using recombinant DNA technology and tagged with histidine (His) to facilitate purification .
BR1033/BS1330_I1029 is annotated as a UPF0283 membrane protein, indicating it is a protein of unknown function (UPF) with a transmembrane domain . Proteins in this category often have poorly characterized functions but are conserved across species, suggesting they may play essential roles.
Recombinant BR1033/BS1330_I1029 is typically produced in E. coli and fused to an N-terminal His tag . The His tag allows for purification using affinity chromatography, where the protein binds to a nickel-charged resin and is later eluted.
Purification Steps:
E. coli cells expressing the His-tagged BR1033/BS1330_I1029 are lysed.
The lysate is passed through a nickel affinity column.
The column is washed to remove unbound proteins.
BR1033/BS1330_I1029 is eluted using a buffer containing imidazole, which competes with the protein for binding to the nickel ions.
The eluted protein is dialyzed or buffer-exchanged to remove imidazole and stabilize the protein.
Brucella species are facultative intracellular bacteria that cause brucellosis, a zoonotic disease . A key aspect of Brucella virulence is their ability to survive and multiply within host phagocytes . Mutagenesis studies have identified several factors required for virulence, including the type IV secretion system (T4SS) encoded by the virB operon .
While BR1033/BS1330_I1029 is annotated as a UPF0283 membrane protein, other Brucella virulence factors have been identified, such as BvfA (Brucella virulence factor A), a small periplasmic protein essential for the virulence of Brucella suis . A BvfA knockout mutant was highly attenuated in both in vitro macrophage infection assays and in vivo in the murine model of brucellosis .
KEGG: bms:BR1033